Somatropin
Who holds supplier records for Somatropin? 3 organisations hold a current record for Somatropin: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: China (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Somatropin: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/somatropin
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Somatropin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIO TECHNOLOGY GENERAL ISRAEL LTDCompany GMP cert on recordActive DMF 20147 · latest filing Dec 2006
- JILIN QIJIAN BIO-PHARMACEUTICAL CO LTDChinaActive DMF 33745 · latest filing Mar 2019
- YIFAN PHARMACEUTICAL (SHANGHAI) CO LTDActive DMF 41783 · latest filing Apr 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Somatropin are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- BIOTECHNOLOGY GENERAL CORPInactive DMF 7037 · filed Jun 1987
- Inactive DMF 6970 · filed Apr 1987
Overview
Somatropin is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1201621).
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Recombinant Human Growth Hormone
- Chemical structure
- Human Growth Hormone
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Somatropin?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Somatropin: BIO TECHNOLOGY GENERAL ISRAEL LTD, JILIN QIJIAN BIO-PHARMACEUTICAL CO LTD (China) and YIFAN PHARMACEUTICAL (SHANGHAI) CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Somatropin Drug Master Files are active?
BIO TECHNOLOGY GENERAL ISRAEL LTD (DMF 20147), JILIN QIJIAN BIO-PHARMACEUTICAL CO LTD (DMF 33745) and YIFAN PHARMACEUTICAL (SHANGHAI) CO LTD (DMF 41783). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Somatropin records mean?
2 organisations have only inactive Type II DMFs for Somatropin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Somatropin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Somatropin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.